Latam Adalimumab Market

LATAM Adalimumab Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

  • Rep Id : TMRGL8716
  • Published On : Jan 2016
  • No. of Pages : 61
  • Category : Pharmaceutical


1. Preface

2. Executive Summary
    2.1. LATAM Adalimumab: Market Snapshot
    2.2. Comparative Analysis: LATAM Adalimumab Market, by Country, 2014 & 2023 (Value %)
    2.3. LATAM Adalimumab Market Revenue, by Application, 2014 (US$ Mn)

3. Industry Analysis: LATAM Adalimumab Market
    3.1. Introduction
    3.2. Market Drivers
          3.2.1.  Driver 1: Favorable Local Regulations
          3.2.2.  Driver 2: Expertise in Biologic Product Research To Support Local And Foreign Investments
    3.3. Market Restraints
          3.3.1. Restraint 1: High Cost of R&D and Clinical trials
          3.3.2. Restraint 2: Lack of reimbursement for biosimilars resulting in high out-of-pocket costs 
    3.4. Market Opportunities
3.4.1. Opportunity 1: LATAM, an attractive base for the biosimilar developers for their product expansion
    3.5. Market Attractiveness Analysis– LATAM Adalimumab Market, by Country (2014) (value %) 
    3.6. Pipeline Analysis: LATAM Adalimumab Market

4. LATAM Adalimumab Market Segmentation – by Application
    4.1. Introduction
    4.2. LATAM Adalimumab Market Revenue, by Application 2013–2023 (US$ Mn)
    4.3. LATAM Adalimumab Market Revenue for Rheumatoid Arthritis, 2013–2023, (US$ Mn)
    4.4. LATAM Adalimumab Market Revenue for Psoriasis, 2013–2023, (US$ Mn)
    4.5. LATAM Adalimumab Market Revenue for Crohn’s Disease, 2013–2023, (US$ Mn)
    4.6. LATAM Adalimumab Market Revenue for Ulcerative Colitis, 2013–2023, (US$ Mn)
    4.7. LATAM Adalimumab Market Revenue for Others, 2013–2023, (US$ Mn)

5. LATAM Adalimumab Market Segmentation – by Country
    5.1. Introduction    
    5.2. LATAM Adalimumab Market Revenue, by Country, 2013–2023 (US$ Mn)
    5.3. Brazil Adalimumab Market Revenue, 2013–2023 (US$ Mn)
    5.4. Mexico Adalimumab Market Revenue, 2013–2023 (US$ Mn)
    5.5. Argentina Adalimumab Market Revenue, 2013-2023 (US$ Mn)
    5.6. Colombia Adalimumab Market Revenue, 2013–2023 (US$ Mn)
    5.7. Rest of LATAM Adalimumab Market Revenue, 2013-2023 (US$ Mn)

6. Recommendations

7. Company Profiles
    7.1. AbbVie, Inc. 
    7.2. Amgen, Inc.
    7.3. Boehringer Ingelheim GmbH
    7.4. Eisai Co., Ltd.
    7.5. Mylan N.V.
    7.6. Novartis AG
    7.7. Pfizer, Inc.